Last month I broke a story about the new, experimental anti-myeloma novel therapy agent, carfilzomib:
This Just In: FDA Announces Fast Track Designation For Carfilzomib.
I asked Nadia Hasan, a representative from the manufacturer of carfilzomib, Onyx ...
↧